AbtBioConsult ApS: Financial statements 2023
CVR: 42368660
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AbtBioConsult ApS (CVR 42368660) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,429,097 and a net result of DKK -626,623 compared with DKK -433,815 the year before. That is a decrease of 26.3% compared with the year before. Equity in the 2023 report amounted to DKK 3,845,139. The solvency ratio was 96.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,429,097
- Profit/Loss
- DKK -626,623
- Equity
- DKK 3,845,139
- Total Assets
- DKK 3,988,888
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.4 mio. | -627 t. | 3.8 mio. | 1 |
| 2022 | - | 1.9 mio. | -434 t. | 4.9 mio. | 1 |
| 2021 | - | 2.5 mio. | -575 t. | 5.3 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AbtBioConsult ApS has published its annual report for 2022. Gross profit came to DKK 1,939,417, and the net result was DKK -433,815.
About AbtBioConsult ApS
AbtBioConsult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anne Bondgaard Tolstrup. The company is owned by Anne Bondgaard Tolstrup. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,937,411 and a net result of DKK 692,691 compared with DKK 485,221 the year before. Equity in the 2025 report amounted to DKK 4,523,051.